The extract of buddleja officinalis maxim. alleviates UVB-induced oxidative damage via the NRF2 pathway in HaCaT cells
Context Buddleja officinalis Maxim., a prominent medicinal plant from the Scrophulariaceae family, is extensively distributed throught China, Korea, Vietnam, and Myanmar. This phytotherapeutic agent has demonstrated significant clinical efficacy in treating various ophthalmic disorders, such as xero...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-07-01
|
| Series: | Pharmaceutical Biology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/13880209.2025.2540348 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|